The enrichment of the marker genes of tumor-immune interface-1 show pro-tumor GO terms such as: negative regulation of intrinsic apoptotic pathway in response to DNA damage by p53 class mediator, negative regulation of plasmacytoid dendritic cell cytokine production (reduce type I interferon production). The gene discussed is TP53; the disease is neoplasm.